| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.13 | 1e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.15 | 1e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.14 | 1e-05 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.13 | 2e-05 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | FK866 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | 0.18 | 7e-05 |